MB

MPM BioImpact Portfolio holdings

AUM $874M
1-Year Est. Return 79.23%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+79.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$874M
AUM Growth
+$263M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$53.3M
2
+$45.7M
3
+$34.2M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$21.6M
5
URGN icon
UroGen Pharma
URGN
+$17.5M

Top Sells

1
+$33.1M
2
+$25.3M
3
+$17.8M
4
ALKS icon
Alkermes
ALKS
+$16.5M
5
VERA icon
Vera Therapeutics
VERA
+$16.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEM icon
1
Cullinan Oncology
CGEM
$916M
$79.2M 9.06%
7,648,268
MDGL icon
2
Madrigal Pharmaceuticals
MDGL
$9.81B
$56.4M 6.45%
96,780
-3,635
LQDA icon
3
Liquidia Corp
LQDA
$2.7B
$48.3M 5.53%
1,400,869
+1,200,869
TRVI icon
4
Trevi Therapeutics
TRVI
$1.53B
$41.2M 4.71%
3,287,087
-119,868
EWTX icon
5
Edgewise Therapeutics
EWTX
$3.22B
$41.1M 4.7%
1,655,256
-65,485
RVMD icon
6
Revolution Medicines
RVMD
$19.7B
$40.3M 4.61%
505,672
+189,950
AGIO icon
7
Agios Pharmaceuticals
AGIO
$1.77B
$35.5M 4.06%
+1,303,373
QURE icon
8
uniQure
QURE
$974M
$33.1M 3.78%
+1,381,628
PTCT icon
9
PTC Therapeutics
PTCT
$5.47B
$32.7M 3.74%
430,013
-8,464
SNDX icon
10
Syndax Pharmaceuticals
SNDX
$1.89B
$28.1M 3.22%
1,337,702
-37,972
DYN icon
11
Dyne Therapeutics
DYN
$2.57B
$27.5M 3.15%
1,405,388
-40,973
TARS icon
12
Tarsus Pharmaceuticals
TARS
$3.21B
$26.9M 3.08%
328,869
-12,627
STOK icon
13
Stoke Therapeutics
STOK
$2.08B
$24.4M 2.8%
770,289
-19,409
ALMS
14
Alumis Inc
ALMS
$3.7B
$23.4M 2.68%
+2,401,992
URGN icon
15
UroGen Pharma
URGN
$1.02B
$22M 2.52%
941,378
+806,378
XENE icon
16
Xenon Pharmaceuticals
XENE
$3.34B
$21.8M 2.49%
485,620
-17,778
PVLA
17
Palvella Therapeutics
PVLA
$1.6B
$21.5M 2.46%
205,745
+138,322
NTRA icon
18
Natera
NTRA
$29B
$21.4M 2.45%
93,551
-5,373
CRVS icon
19
Corvus Pharmaceuticals
CRVS
$1.53B
$21.1M 2.42%
+2,743,671
DBVT
20
DBV Technologies
DBVT
$1.15B
$19.1M 2.19%
996,825
-57,679
RLAY icon
21
Relay Therapeutics
RLAY
$1.78B
$18.9M 2.16%
2,232,451
-50,229
GLUE icon
22
Monte Rosa Therapeutics
GLUE
$1.35B
$18.4M 2.11%
+1,173,376
DRUG
23
Bright Minds Biosciences
DRUG
$820M
$18M 2.06%
+230,147
PTGX icon
24
Protagonist Therapeutics
PTGX
$5.76B
$17.4M 1.99%
+199,471
ENGN icon
25
enGene Holdings
ENGN
$677M
$16.6M 1.9%
1,840,898
+1,310,599
1
2 3